To access this content, you must purchase a Premium membership, or log in if you are a member.
Novelos Therapeutics prices public offering
Novelos Therapeutics Inc., a Madison company developing drugs to diagnose and treat cancer, said Friday it is pricing a public offering of 5,420,800 units at $1 each. (JOURNAL SENTINEL, 6/11)